Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 17, 2020
[Survey of Methotrexate Prescription and Blood Concentration in Patients Treated with High-Dose Methotrexate]Shunsuke Kobayashi, Takeo Yasu, Kenji Momo, et al.International Journal of Clinical Pharmacology and Therapeutics|September 20, 2016
The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphomaTakeo Yasu, Shunsuke Kobayashi, Mai Horii, et al.Chemotherapy|June 16, 2024
Successful Isavuconazole Treatment for Pulmonary Mucormycosis in a Patient Intolerant to Liposomal Amphotericin B with Pharmacokinetic Insights: A Case ReportTakeo Yasu, Makoto Hoshino, Naoya Sakamoto, et al.BMJ Case Reports|January 3, 2025
Cholestasis due to biliary obstruction can cause cardiogenic shock with bradycardia by delaying the elimination of arotinololYuki Iizuka, Yasunori Urayama, Takeo Yasu, et al.Medical Oncology (Northwood, London, England)|October 12, 2022
Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemiaMasayuki Kobayashi, Takeo Yasu, Ken Suzaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[A case of therapy for bevacizumab-induced hypertension]Takeo Yasu, Yoshiyuki Miyasaka, Hideo Chubachi, et al.International Journal of Clinical Pharmacology and Therapeutics|January 28, 2020
Potential thiamine deficiency in elderly patients with gastrointestinal cancer undergoing chemotherapyTakeo Yasu, Yohei Iimura, Kenji Momo, et al.Cancer Chemotherapy and Pharmacology|December 7, 2024
Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)Motohiro Matsui, Takeo Yasu, Atsushi Makimoto, et al.Journal of Clinical Pharmacy and Therapeutics|May 8, 2019
Risk factors affecting the failed low-density lipoprotein level achievement rate in working-age male population at high cardiovascular riskKenji Momo, Takeo Yasu, Hiroshi Yasui, et al.Plos One|October 9, 2019
Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in JapanTakeshi Horii, Kenji Momo, Takeo Yasu, et al.Pageof 8